Tiaa Fsb trimmed its stake in shares of Xylem Inc (NYSE:XYL) by 40.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 50,702 shares of the industrial products company’s stock after selling 34,265 shares during the quarter. Tiaa Fsb’s holdings in Xylem were worth $4,007,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Halsey Associates Inc. CT purchased a new position in shares of Xylem in the 4th quarter worth about $626,000. Pathlight Investors LLC purchased a new position in shares of Xylem in the 4th quarter worth about $325,000. Rehmann Capital Advisory Group boosted its holdings in shares of Xylem by 7,887.0% in the 3rd quarter. Rehmann Capital Advisory Group now owns 15,974 shares of the industrial products company’s stock worth $200,000 after purchasing an additional 15,774 shares in the last quarter. Hotaling Investment Management LLC purchased a new position in shares of Xylem in the 4th quarter worth about $1,111,000. Finally, Mackay Shields LLC boosted its holdings in shares of Xylem by 9.8% in the 4th quarter. Mackay Shields LLC now owns 31,442 shares of the industrial products company’s stock worth $2,097,000 after purchasing an additional 2,794 shares in the last quarter. Institutional investors own 86.64% of the company’s stock.
In related news, SVP Claudia S. Toussaint sold 8,215 shares of the firm’s stock in a transaction that occurred on Wednesday, March 6th. The stock was sold at an average price of $76.37, for a total transaction of $627,379.55. Following the completion of the transaction, the senior vice president now owns 59,008 shares of the company’s stock, valued at approximately $4,506,440.96. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Kenneth Napolitano sold 35,526 shares of the firm’s stock in a transaction that occurred on Monday, February 4th. The shares were sold at an average price of $70.17, for a total value of $2,492,859.42. The disclosure for this sale can be found here. Insiders sold a total of 80,195 shares of company stock valued at $6,000,933 in the last three months. Corporate insiders own 0.85% of the company’s stock.
Shares of NYSE:XYL opened at $82.44 on Wednesday. Xylem Inc has a 52-week low of $60.65 and a 52-week high of $82.70. The company has a market capitalization of $14.72 billion, a PE ratio of 28.63, a PEG ratio of 1.41 and a beta of 1.14. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.51 and a quick ratio of 1.08.
Xylem (NYSE:XYL) last announced its earnings results on Thursday, January 31st. The industrial products company reported $0.88 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.88. Xylem had a return on equity of 19.89% and a net margin of 10.54%. The firm had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.36 billion. Equities research analysts forecast that Xylem Inc will post 3.31 EPS for the current year.
A number of equities analysts have recently issued reports on XYL shares. Stifel Nicolaus upgraded Xylem from a “hold” rating to a “buy” rating and upped their price objective for the stock from $72.00 to $75.00 in a report on Wednesday, December 19th. Zacks Investment Research upgraded Xylem from a “hold” rating to a “buy” rating and set a $79.00 price objective for the company in a report on Monday, February 4th. Oppenheimer set a $80.00 price objective on Xylem and gave the stock a “buy” rating in a report on Monday, February 4th. Boenning Scattergood restated a “buy” rating on shares of Xylem in a report on Friday, March 22nd. Finally, BMO Capital Markets restated a “buy” rating and set a $85.00 target price on shares of Xylem in a report on Monday, February 25th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $79.64.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Recommended Story: Stock Split
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.